PATHOVACS INCORPORATED

Ames, IA · Defense

Diagnostic assays for early detection of biothreat agent infections

Grants
$1.8M
4 awards
Sector median: 2
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 0

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Agriculture · Immunologically Cross Reactive Proteins For Broadly Protective Campylobacter Chicken Vaccines$99,750
Federal grantDepartment of Agriculture · Broadly Protective Porcine Streptococcus Suis Vaccines$99,546
Federal grantDepartment of Defense · Phase II · Circulating Diagnostic Markers of Infectious Disease$975,606
Federal grantDepartment of Agriculture · **awards Issued Prior To January 20, 2025, Were Funded Under Previous Administrations And May Not Reflect The Priorities And Policies Of The Current Administration.** This SBIR Phase II Project Builds On Results Of A Previous SBIR Phase I Project, Wherein, We Employed A Proprietary Discovery Tool To Identify Vaccine Components (proteins) Shared By Diverse Streptococcus Suis Variants (serotypes) That Cause Disease In Different Regions Of The World. Specifically, We Demonstrated That A Vaccine Com$649,999
Federal grant · SBIR/STTR

Peer position

Defense · 1442 companies · ranked on federal contract value
Defense companies ranked by federal contract value
#CompanyContractsDisclosed equity
1186LENZNER RESEARCH LLC——
1187CRFS Holdings, LLC—$5.8M
1188Boumarang Inc.——
1189PATHOVACS INCORPORATED——
1190AQUILA, INC.——
1191Dev-Lock Systems, Inc.—$300K
1192GoPlug Bags, Inc.—$338K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Means And Methods For Producing Antiproteome Antibodies And Identifying Conserved Unique Or Differentially Expressing Molecules Of Organsimsapplication

Regulatory activity · Defense

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.